Therapy-treatment (PDT) on Acne, a study to optimize the number of treatments, the right light-dose and the right pre-treatment in order to obtain a longterm remission-time
Phase 1
- Conditions
- AcneMedDRA version: 17.1Level: HLTClassification code 10000497Term: AcnesSystem Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Registration Number
- EUCTR2014-005235-13-SE
- Lead Sponsor
- Sahlgrenska University hospital of gothenburg Department of dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Inclusion criteria
Patients with papulopustular acne.
Male or female between 18-25 years of age who has signed a written informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 46
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Pregnant or breast-feeding.
Patients who have been treated with tetracycline up to less than a month before PDT treatment.
Local acne treatment until up to one week before PDT treatment.
Conditions associated with poor protocol compliance, e.g. excessive use of alcohol or drug abuse.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method